title: [The active management of the placental period with Remestyp].
abstract: The aim of this prospective study is to asses, the possibility to use Remestyp after the delivery of the head as a prophylaxis of blood lost during the third stage of labor. The material includes 209 cases: 82 with bolus dose of 0.2 mg Methergin, 54 cases with 10 ME Oxytocin, 32 parturition with 200 mg Remestyp, and 41 controls without any uterostonics during the placental period. The blood lost is assessed by gravimetric method. The results show that the total blood lost from the delivery of the neonate to two hours after it is significantly lower in active management of labor than in expectant one. The type of uterostonic is not essential in regard of total blood lost. The prophylactics of blood lost with Remestyp has best results in cases of stimulated with Oxytocin infusion labor. The active management of third stage of labor with Methergin or Remestyp has less complication than are used oxytocin or without uterostonics. The mean time for delivery of placenta is shortest in the group with Remestyp. The three uterostonics in mansion doses do not influenced significantly the artery pressure. Our experience demonstrates that Remestyp can be used for active management of third stage of labor and the results are as those with Methergin. Remestyp is preferable when are expected significant lacerations of the birth canal.
authors.forename: A
authors.initials: A
authors.lastname: Dimitrov
authors.forename: A
authors.initials: A
authors.lastname: Nikolov
authors.forename: K
authors.initials: K
authors.lastname: Krŭsteva
authors.forename: L
authors.initials: L
authors.lastname: Lazarova
authors.forename: E
authors.initials: E
authors.lastname: Gŭrchev
authors.forename: I
authors.initials: I
authors.lastname: Karag'ozov
mesh_terms: D005260:Female; D006801:Humans; D007749:Labor Stage, Third / Q000187:drug effects*; D008236:Lypressin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D008755:Methylergonovine / Q000008:administration & dosage; D010120:Oxytocics / Q000008:administration & dosage; D010121:Oxytocin / Q000008:administration & dosage; D011247:Pregnancy; D011446:Prospective Studies; D011644:Puerperal Disorders / Q000517:prevention & control; D000077585:Terlipressin; D013997:Time Factors; D014592:Uterine Hemorrhage / Q000517:prevention & control; D014662:Vasoconstrictor Agents / Q000008:administration & dosage*
chemical_list: D010120:Oxytocics; D014662:Vasoconstrictor Agents; D010121:Oxytocin; D008236:Lypressin; D000077585:Terlipressin; D008755:Methylergonovine